3 transcripts
VRNA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
statement there around medical benefit versus pharmacy benefit. We believe the majority of our prescriptions will run through the medical benefit side
VRNA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
up the bulk of the majority of the patients that are treated in the U.S. So we see its application quite wide. And so we expect utilization across
VRNA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
of those individually and I look at market access and trade, between now and PDUFA, a vast majority of our work will be spent setting up our channel and our
- Prev
- 1
- Next